A recent poster presentation at Psych Congress Elevate by Johnson & Johnson has placed esketamine nasal spray, marketed as Spravato,…
Read More

A recent poster presentation at Psych Congress Elevate by Johnson & Johnson has placed esketamine nasal spray, marketed as Spravato,…
Read More
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in 1962 while diligently searching for a safer…
Read More
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in a quest for a safer anesthetic, the…
Read More
Johnson & Johnson is intensifying its efforts to expand the market footprint of Spravato (esketamine) for treatment-resistant depression (TRD), leveraging…
Read More
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis while searching for a safer anesthetic, the molecule…
Read More
The Centers for Disease Control and Prevention (CDC) has implemented a temporary suspension of its infectious disease testing services for…
Read More
A temporary suspension of infectious disease testing services at the Centers for Disease Control and Prevention (CDC) has initiated a…
Read More
The search for dark matter, the invisible substance believed to constitute approximately 85% of the matter in the universe, has…
Read More
As the global appetite for artificial intelligence and cloud computing continues to accelerate, the infrastructure supporting these technologies is facing…
Read More
The pursuit of dark matter remains one of the most profound challenges in modern astrophysics, as this invisible substance is…
Read More